Our products

Reaching more than 130 countries
Our product portfolio is sold in over 130 countries on 5 continents.
Select the therapeutic area

Select consultation area *(mandatory)

Arcid


Digestive and metabolic system

Arnidol


Personal care and Hygiene

Axiras

Hidrosmin

Cardiovascular System
With prescription

Axofin

Doxofylline

Respiratory System
With prescription

Ayrinal

Bilastine

Dermatology
Respiratory System
With prescription

Azzavix

Mesalazine

Digestive and metabolic system
With prescription

Bactinel


Personal care and Hygiene

Beclometasona

Beclomethasone Dipropionate

Respiratory System
With prescription

Beclometasona Nasal

Beclomethasone Dipropionate

Respiratory System
With prescription

Bekunis

Bisacodyl

Digestive and metabolic system

Bilanoa

Bilastine

Dermatology
Respiratory System
With prescription

Bilastine

Bilastine

Dermatology
Respiratory System
With prescription

Bilaxin

Bilastine

Dermatology
Respiratory System
With prescription

Bilaxten

Bilastine

Dermatology
Respiratory System
With prescription

Bilaz

Bilastine

Dermatology
Respiratory System
With prescription
Pharmacovigilance

Have you noticed a side effect?

We are here to help you and continue our research to improve our solutions and the quality of our medicines.


News

Economic and Financial News
March 25th, 2025

Faes Farma signs an agreement to acquire Laboratorios Edol, a leader in ophthalmology in Portugal

Ophthalmology represents a key strategic opportunity for Faes Farma as it is a therapeutic area with expected double-digit growth. This milestone reinforces Faes Farma’s international growth strategy and consolidates its position in […]

R+D+I
January 29th, 2024

iFEROL: Development of new medications based on Vit D analogues for the treatment of Vitamin D deficiency and associated pathologies